Efficacy and Safety of Revacept in Patients Undergoing Elective PCI for Stable Ischemic Heart Disease

This randomized clinical trial evaluates the efficacy and safety of revacept, a novel, lesion-directed antithrombotic drug, acting as a competitive antagonist to platelet glycoprotein VI.